Study guide

10.4 Benign Prostatic Hyperplasia & Renal Calculi

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

10.4 Benign Prostatic Hyperplasia & Renal Calculi

Key Takeaways Explain This Topic AI

Benign Prostatic Hyperplasia (BPH) arises in the transitional zone of the prostate causing lower urinary tract symptoms (LUTS), whereas Prostate Adenocarcinoma predominantly develops in the peripheral zone.

Pharmacotherapy for BPH involves Alpha-1 blockers (Tamsulosin) for rapid dynamic symptom relief and 5-Alpha Reductase Inhibitors (Finasteride) to reduce prostate volume by inhibiting DHT synthesis.

Transurethral Resection of the Prostate (TURP) is the gold-standard surgical repair; TURP syndrome is a life-threatening complication caused by systemic absorption of hypotonic non-conductive irrigation fluid (glycine) resulting in dilutional hyponatremia.

Non-Contrast CT (NCCT) of the abdomen and pelvis is the gold-standard diagnostic imaging for renal and ureteric colic; uric acid stones are radio-lucent on plain X-ray but clearly visible on NCCT and respond to urinary alkalinization.

Interventional stone management is determined by size and location: ESWL for renal stones <2 cm, PCNL for renal stones >2 cm or staghorn calculi, and URS/RIRS with Holmium laser lithotripsy for ureteric stones.

Last updated: July 2026

Benign Prostatic Hyperplasia & Renal Calculi

Urological emergencies and elective reconstructive procedures comprise a significant portion of general surgery in UPSC CMS. Mastery of prostatic disease pathology, surgical options, and urinary tract stone management algorithms is essential for clinical excellence.

  • 1. Benign Prostatic Hyperplasia (BPH)
  • Prostatic Zonal Anatomy (McNeal's Zones)

Transitional Zone : Surrounds the proximal pre-prostatic urethra. Site of origin of Benign Prostatic Hyperplasia (BPH) .

Peripheral Zone : Comprises 70% of glandular prostate, located posteriorly. Site of origin of Prostate Carcinoma (palpable on Digital Rectal Exam - DRE).

Central Zone : Surrounds ejaculatory ducts.

Pathophysiology & Clinical Features

Hormonal Basis : Dihydrotestosterone ( DHT ), synthesized locally from circulating testosterone by the enzyme 5-alpha reductase (Type 2) , binds to androgen receptors in stromal and epithelial prostatic cells, driving nodular hyperplasia.

Lower Urinary Tract Symptoms (LUTS) :

Storage (Irritative) Symptoms : Frequency, urgency, nocturia, urge incontinence.

Voiding (Obstructive) Symptoms : Hesitancy, weak stream, intermittency, straining, terminal dribbling, sensation of incomplete emptying.

Evaluation : International Prostate Symptom Score ( IPSS ), DRE (reveals smooth, elastic, symmetrical enlarged prostate with preserved median sulcus), Serum PSA (normal <4 ng/mL; rules out cancer), Uroflowmetry (peak flow rate Qmax <10 mL/s indicates bladder outlet obstruction), Post-Void Residual (PVR) urine volume (>100 mL is abnormal).

Pharmacotherapy of BPH

Alpha-1 Adrenergic Blockers ( Tamsulosin, Silodosin, Alfuzosin ): Selective alpha-1A receptor antagonists. Relax smooth muscle tone in the prostate capsule and bladder neck. Provide rapid symptom relief within days. Side effects : Retrograde ejaculation, orthostatic hypotension, Intraoperative Floppy Iris Syndrome (IFIS during cataract surgery).

5-Alpha Reductase Inhibitors (5-ARIs) ( Finasteride, Dutasteride ): Block conversion of testosterone to DHT. Induce prostate epithelial apoptosis, reducing prostate volume by 20-30% over 6 months. Halves serum PSA levels (baseline PSA must be multiplied by 2 for cancer screening interpretation).

Combination Therapy : Tamsulosin + Dutasteride is indicated for moderate-to-severe LUTS with prostate volume >30 cc.

Surgical Management: TURP & Complications

Indications for Surgery : Refractory urinary retention, recurrent UTIs, recurrent gross hematuria, renal impairment attributable to BPH, secondary bladder calculi.

Gold Standard : Transurethral Resection of the Prostate (TURP) .

TURP Syndrome :

Pathophysiology : Excessive intravascular absorption of hypotonic non-conductive irrigation fluid (1.5% Glycine or Sorbitol) through opened prostatic venous sinuses during prolonged resection (>60 mins).

Clinical Presentation : Dilutional Hyponatremia (Na+ <120 mEq/L) and fluid overload. Causes confusion, visual disturbances (transient blindness due to glycine ocular toxicity), nausea, bradycardia, pulmonary edema, seizures, and coma.

Prevention : Limit resection time to <60 minutes, keep irrigation bag height <60 cm above patient, use Bipolar TURP (uses 0.9% normal saline irrigation, eliminating TURP syndrome).

Treatment : Hypertonic (3%) Saline infusion slow rate, IV Furosemide, ICU supportive care.

  • 2. Urolithiasis (Renal Calculi)
  • Chemical Composition & Radiogenicity Table

Stone Type Percentage Radio-opacity (X-ray KUB) Crystal Morphology Etiology & Risk Factors

Calcium Oxalate 75 - 80% Radio-opaque Envelope / Dumbbell shaped Hypercalciuria, hyperoxaluria, inflammatory bowel disease (Crohn's), vitamin C excess.

Struvite (Triple Phosphate) 10 - 15% Moderately Radio-opaque Coffin-lid shaped Infection with urease-producing bacteria ( Proteus , Klebsiella ). Alkaline urine (pH >7.2). Forms Staghorn Calculi .

Uric Acid 5 - 8% Radio-lucent (invisible on X-ray) Pleomorphic / Rhomboid Hyperuricemia, gout, acidic urine (pH <5.5). Dissolves with urinary alkalinization .

Calcium Phosphate 5% Very Radio-opaque Amorphous / Rosette Associated with Primary Hyperparathyroidism and Renal Tubular Acidosis (RTA Type 1).

Cystine 1 - 2% Faintly Radio-opaque ('Ground-glass') Hexagonal Autosomal recessive defect in COLA amino acid transport. Positive Cyanide-Nitroprusside test.

3. Clinical Features & Diagnostic Imaging

Renal Colic : Sudden, excruciating, waxing-and-waning flank pain radiating to the groin, labia, or testicle (referred pain along T10-L2 dermatomes). Accompanied by micro/gross hematuria, nausea, vomiting, and costovertebral angle tenderness.

Gold-Standard Investigation : Non-Contrast Computed Tomography (NCCT) of Abdomen and Pelvis . Detects 99% of all stones including radio-lucent uric acid stones (except rare indinavir protease inhibitor stones). Provides exact stone location, dimensions, and Hounsfield Unit (HU) density.

  • 4. Management Algorithms for Urolithiasis
  • Conservative / Medical Expulsive Therapy (MET)

Stones <5 mm have an 80-90% probability of spontaneous passage.

Treatment: Adequate hydration (>2.5-3 L/day), analgesia (NSAIDs: Diclofenac/Ketorolac preferred over opioids), and Alpha-blockers (Tamsulosin) to relax distal ureteric smooth muscle.

Interventional Procedures Table

Modality Primary Indications Key Contraindications & Limitations

ESWL (Extracorporeal Shock Wave Lithotripsy) Renal pelvic or upper pole stones <2 cm ; upper ureteric stones <1 cm. Contraindications : Pregnancy, uncorrected bleeding diathesis, untreated UTI, severe skeletal deformity, aortic aneurysm, distal anatomical obstruction.

PCNL (Percutaneous Nephrolithotomy) Renal stones >2 cm , Staghorn Calculi , lower pole stones >1 cm, or failed ESWL. Invasive; percutaneous tract established into renal pelvis through posterior calyx under fluoroscopy. Risks: hemorrhage, pneumothorax.

URS / RIRS (Ureteroscopy / Retrograde Intrarenal Surgery) URS : Choice for middle and lower ureteric stones.; RIRS : Flexible scope with Holmium:YAG laser for intrarenal stones <2 cm. Method of choice in obese patients, patients on anticoagulants, or pregnant women needing intervention.

Open / Laparoscopic Stone Surgery Complex failed stones, anatomical anomalies (horseshoe kidney). Rarely performed in modern urological practice (<1-2% of cases).

Loading diagram... Urinary Tract Calculi Management Algorithm